Predictive factors for diabetes remission after bariatric surgery

Area of Science:

• Metabolic Surgery
• Endocrinology
• Obesity Medicine

Background:

• Bariatric surgery is a proven method for achieving type 2 diabetes mellitus (T2DM) remission in severely obese individuals.
• Remission after laparoscopic Roux-en-Y gastric bypass (LRYGB) is often rapid and not solely dependent on weight loss.
• Identifying preoperative predictors of T2DM remission is crucial for patient selection and optimizing surgical outcomes.

Purpose of the Study:

• To identify independent predictors of T2DM remission following bariatric surgery.
• To compare the efficacy of laparoscopic sleeve gastrectomy (LSG) versus LRYGB in achieving T2DM remission.
• To inform clinical decision-making regarding bariatric procedures for T2DM management.

Main Methods:

• Retrospective review of 207 T2DM patients undergoing LSG or LRYGB between January 2008 and July 2014.
• Diabetes remission defined by absence of hypoglycemic medications, fasting glucose < 7.0 mmol/L, and HbA1c < 6.5%.
• Multivariable logistic regression analysis employed to determine predictive factors for remission.

Main Results:

• Nearly half (49.8%) of patients achieved T2DM remission at one year post-surgery.
• LRYGB demonstrated significantly higher odds of T2DM remission compared to LSG (OR 6.58, p < 0.001).
• Shorter diabetes duration (OR 0.91, p = 0.032) and not using long-acting insulin (OR 0.0011, p = 0.013) were significant predictors of remission.

Conclusions:

• The type of bariatric procedure is an independent predictor of T2DM remission.
• Shorter diabetes duration and the absence of long-acting insulin use are crucial factors associated with successful T2DM remission post-bariatric surgery.
• These findings aid in selecting patients most likely to achieve T2DM remission through bariatric interventions.